# Oncofactor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oncofactor

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.oncofactor.com
- Total disclosed funding: $5.1M
- Latest round: Series A (May 24, 2011)
- Investors on record: 6

## About

Oncofactor specializes in domain name acquisition and leasing services, facilitating the process for businesses and individuals to secure digital real estate effectively.Oncofactor provides services in domain name acquisition and leasing. The company is headquartered in Seattle, US. It has secured USD 1.00 mn in funding from investors as of August 30, 2013. The company's founder has a history of entrepreneurial ventures, although specific previous companies have not been disclosed.Oncofactor.com primarily offers domain name acquisition and leasing services, focusing on simplifying the process of obtaining digital real estate for businesses and individuals. The core product is the domain name itself, available for a one-time purchase price of USD 3,495 or through a lease-to-own option at USD 168 per month. This service targets a diverse clientele, including startups and established businesses, ensuring secure transactions and efficient transfers for a hassle-free experience globally.Revenue generation for Oncofactor is primarily derived from the sale and leasing of domain names. Customers can choose to purchase a domain outright for USD 3,495 or opt for the Lease to Own model, which breaks down the cost into monthly payments of USD 168. Each transaction includes comprehensive support, ensuring that customers feel secure throughout the purchasing process. The structured pricing plans accommodate different financial capacities, expanding the potential customer base and enhancing retention.Oncofactor is focusing on expanding its product offerings by developing new leasing models and exploring additional digital real estate services. The company is also targeting geographic expansion into European and Asian markets by 2024. The recent funding of USD 1.00 mn will be allocated towards marketing initiatives and enhancing their digital infrastructure to support these growth strategies.

## Funding rounds

- Series A, May 24, 2011, $5.1M — ARCH Venture Partners, OVP Venture Partners, Alexandria Venture Investments, Amgen Ventures, WRF Capital, Accelerator Life Science Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series A
- Accelerator Life Science Partners (https://capitalatlas.ai/funds/accelerator-life-science-partners) — Series A